Literature DB >> 2784111

B cell precursors are present in the thymus during early development.

H Kimoto1, T Shirasawa, M Taniguchi, T Takemori.   

Abstract

An in vitro system for transforming immature lymphoid cells present in the thymus at early development has been established. By phenotype analysis of the transformants obtained, we observed that B cell precursors, susceptible to Abelson murine leukemia virus (A-MuLV)- or Harvey murine sarcoma virus (H-MuSV)-induced lymphogenesis, were present at high frequency in the fetal thymus of BALB/c mice. These precursors recolonized alymphoid thymus lobes in vitro, as do T cell precursors. It was further observed that B precursors in the fetal liver were also capable of recolonizing alymphoid thymus lobes and were stored in a thymic environment. These results suggest that stroma cells of the fetal thymus may possess the capacity to support the growth of B precursors. On the other hand, B cell precursors sensitive to the viral transformation were undetectable in the fetal thymus of C57BL/6, although immunohistochemical analysis suggested their presence. However, in the fetal liver of the same strain, B precursors recolonizing alymphoid thymus in vitro were sensitive to the viral transformation. Based on these results, we will discuss both the role and fate of thymic B precursors. In addition, we also obtained T cell lymphomas at different stages of differentiation from the fetal thymus of C57BL/6 infected with A-MuLV or H-MuSV. These data indicate the usefulness of our system in establishing cell lines derived from intrathymic lymphogenesis at early development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784111     DOI: 10.1002/eji.1830190116

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

1.  Traffic of peripheral B and T lymphocytes to hyperplastic, preneoplastic thymuses of AKR mice.

Authors:  S A Michie; R V Rouse
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Intrathymic presentation by dendritic cells and macrophages: their role in selecting T cells with specificity for internal and external nominal antigen.

Authors:  M Zöller
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

3.  Intrathymic induction of neonatal tolerance to Mls-1a determinant: clonal deletion and clonal anergy by haematolymphoid cells.

Authors:  S Ideyama; M Hosono; S Imamura; M Tomana; Y Katsura
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

4.  Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras.

Authors:  M Ogimoto; Y Yoshikai; G Matsuzaki; S Ohga; K Matsumoto; K Nomoto
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

5.  Individual germinal centres of myasthenia gravis human thymuses contain polyclonal activated B cells that express all the Vh and Vk families.

Authors:  V Guigou; D Emilie; S Berrih-Aknin; F Fumoux; M Fougereau; C Schiff
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

6.  Transplantation tolerance is unrelated to superantigen-dependent deletion and anergy.

Authors:  J Salaün; A Bandeira; I Khazaal; O Burlen-Defranoux; V Thomas-Vaslin; M Coltey; N M Le Douarin; A Coutinho
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

7.  Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells.

Authors:  V A Boussiotis; L M Nadler; J L Strominger; A E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Elimination of self-tolerogen turns nonresponder mice into responders.

Authors:  D Vidović
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

9.  Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells.

Authors:  M Inaba; K Inaba; M Hosono; T Kumamoto; T Ishida; S Muramatsu; T Masuda; S Ikehara
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.